Traders assign a strong 93.5% probability to no new COVID variant of concern being designated before 2027 because genomic surveillance through mid-2026 shows only sublineages under monitoring, such as XFG and BA.3.2 derivatives, without any meeting WHO criteria for elevated transmissibility, severity, or immune escape. European and global tracking data through July 2026 confirm zero active variants of concern, reflecting the virus's shift toward endemic circulation with incremental Omicron evolution rather than disruptive shifts. Recent increases in detections of certain lineages have not produced higher case severity or overwhelmed health systems, supporting the market consensus that a rapid escalation remains improbable in the limited remaining timeframe.